Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection

Evidence of the Xenex Germ-Zapping Robot’s ability to help hospitals reduce Hospital Acquired Infection (HAI) rates continues to grow. Xenex Disinfection Services today announced two new infection reduction posters which were presented by healthcare facilities that utilize the Xenex Pulsed Xenon Full Spectrum™ ultraviolet (UV) room disinfection system to destroy the microorganisms that cause HAIs. The posters were presented at the Association for Professionals in Infection Control and Epidemiology (APIC) Annual Conference taking place in Nashville, TN, June 27-29, 2015.

Xenex offers the only UV disinfection technology shown, in peer reviewed published studies, to effectively reduce HAI rates. Designed for speed, effectiveness and ease of use, hospital cleaning staff operate the robot without disrupting hospital operations. The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores in a five-minute disinfection cycle. Without contact or chemicals, the robot eliminates harmful microorganisms safely and effectively. The Xenex robot destroys C.diff spores in less than five minutes and other microorganisms in even less time.

The poster entitled, ““The Impact of Pulsed Xenon Ultraviolet Light on Hospital Acquired Infection Rates in a Tertiary Care Community Hospital” reported the impact of Xenex’s disinfection system as an adjunct to traditional cleaning methods on multidrug-resistant organisms (MDRO) infection rates in the intensive care unit (ICU) and non-ICU areas at Orlando Health South Seminole Hospital (FL). The hospital disinfected all isolation discharges within its ICU and experienced a 61 percent decrease in MRSA, VRE and Clostridium difficile (C.diff) infection rates in the ICU. The hospital disinfected only C.diff discharges throughout the rest of the facility, which resulted in a 41 percent decrease in C.diff infections facility-wide. According to the authors of the poster, the reduction in infections saved the hospital $730,000 over a 22 month period.

“We have been very pleased with the results of the Xenex UV room disinfection system. We know that with Xenex, we are creating a safer patient environment because we are getting the dangerous pathogens out of the environment before they can cause infections and harm patients. The results are evident and we are sharing them in hopes that other hospitals will follow our lead. We’ve seen a significant decrease in infections and a return on our investment,” said Dr. Thomas Kelley, Chief Quality Officer of Orlando Health South Seminole Hospital.

Environmental contamination may pose an even greater challenge in long-term care facilities than acute care settings because of the extended length of stay for patients and patient-to-patient contact. Patients inhabit rooms for weeks to months at a time, making thorough disinfection a challenge for environmental services. With the goal of preventing hospital-acquired C.diff infection and its associated rebounds and recurrence, a Texas skilled nursing facility (SNF) implemented Xenex technology to enhance its environmental disinfection practices. Their infection reduction results are significant and offer great promise for other skilled nursing facilities.

The poster entitled “The Effect of Pulsed Xenon Ultraviolet Disinfection and Enhanced Chemical Disinfection of Surfaces on Incidence and Recurrence of Clostridium difficile Cases within a Skilled Nursing Facility” reports on Morningside Ministries at The Manor’s nearly 80 percent reduction in hospital acquired C.diff infection rates. In an effort to decrease C.diff occurrences, the facility retrained staff on hand hygiene practices and implemented the use of sodium hypochlorite cleaning. No immediate change in infection rates was seen, so the facility began using a Xenex robot to disinfect all C.diff isolation rooms and all common areas (dining room and community living areas).

Following implementation of the Xenex robot, the SNF’s C.diff infection rate dropped 76.8 percent.

Morningside Ministries credits ease of integration of the Xenex system as part of its ability to achieve high environmental disinfection compliance.

“This validation from Morningside Ministries and South Seminole Hospital is similar to the data we are seeing from many of our customers after they began using Xenex robots for room disinfection. Three hospitals have published their HAI reductions in peer-reviewed journals and several more are in press or in review,” said Mark Stibich, co-founder and Chief Scientific Officer at Xenex. “Xenex has a team of experienced infection preventionists, epidemiologists and account managers that work closely with the hospital to rapidly integrate the robots into the hospital's operations to ensure their proper use and deployment. We are committed to helping solve this global health crisis and our technology is a proven weapon in the battle against HAIs.”

Only UV Disinfection System Proven to Reduce HAI Rates

MD Anderson Cancer Center, the Central Texas Veterans Health Care System, Cooley Dickinson Health Care (an affiliate of Massachusetts General Hospital and Partners HealthCare System) and other hospitals have published 11 studies providing evidence of the Xenex robot’s efficacy in highly regarded scientific journals that include the American Journal of Infection Control (AJIC), Journal of Infection Prevention, Infection Control & Hospital Epidemiology (ICHE) and BMC Infectious Diseases. Hospitals that purchased Xenex robots have reported greater than 50 percent decreases in methicillin-resistant Staphylococcus aureus (MRSA) and C.diff infection rates in peer-reviewed literature, documenting how they used the Xenex robot in their real-world hospital environment to reduce infection rates.

With a proven five-minute disinfection cycle for C.diff and less than 90 seconds for other pathogens, the robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including: patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas. Nearly 300 hospitals, Veterans Affairs, DoD, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S. and Europe use Xenex robots.

Stop HAIs & Avoid HAC Penalties

The Centers for Medicare and Medicaid Services (CMS) is now measuring C.diff and MRSA Standardized Infection Ratios (SIR) scores as key performance standards in the Value Based Purchasing (VBP) and Hospital Acquired Condition (HAC) Reduction programs. Hospitals performing in the bottom quartile of the HAC program face a one percent reduction in inpatient Medicare reimbursement with HAIs now comprising 75 percent of the score. VBP puts an additional two percent of inpatient Medicare reimbursement at risk with potential for up to a two percent incentive. To demonstrate the potential impact that HAI reductions could have on their bottom line, Xenex provides hospitals with an ROI model, an interactive calculator that shows a facility or health system the clinical and financial impact of adopting a successful environmental disinfection program, based on that facility’s reported data.

Source: http://www.businesswire.com/news/home/20150629006152/en/Studies-Show-Decrease-Hospital-Acquired-Infections-Xenex#.VcDkX7V8rCo

June 29th 2015 back

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more